Companies / Olema Pharmaceuticals, Inc. / Activity

Activity — Olema Pharmaceuticals, Inc.

34 moves.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 2, 2026Austin Sasha Lu
Executive
GrantCommon Stock$0+12K
+260.70%
16,188
0.02% of shares
low
Jan 13, 2026Myles David C.
Executive
SellCommon Stock$5.7K-200
-0.04%
542,761
0.62% of shares
low
Mar 4, 2026Mitchell Shawnte
Executive
SellComon Stock$5.8K-233
-100.00%
0
0.00% of shares
low
Mar 3, 2026Mitchell Shawnte
Executive
ExerciseCommon Stock$65.5K+15K
15,000
0.02% of shares
low
Jan 14, 2026Harmon Cyrus
Director
SellCommon Stock$101.6K-3K
-0.47%
737,770
0.84% of shares
medium
Jan 13, 2026Kovacs Shane William Charles
Executive
SellCommon Stock$107.1K-4K
-1.57%
239,727
0.27% of shares
medium
Mar 4, 2026Mitchell Shawnte
Executive
ExerciseCommon Stock$109.3K+25K
25,000
0.03% of shares
low
Jan 14, 2026Myles David C.
Executive
ExerciseCommon Stock$243.5K+50K
+9.21%
592,761
0.68% of shares
low
Jan 13, 2026Myles David C.
Executive
ExerciseCommon Stock$243.5K+50K
+9.21%
592,761
0.68% of shares
low
Jan 20, 2026Harmon Cyrus
Director
SellCommon Stock$268.8K-10K
-1.36%
727,770
0.83% of shares
medium
Jan 12, 2026Myles David C.
Executive
SellCommon Stock$283.4K-10K
-6.46%
144,846
0.17% of shares
medium
Mar 3, 2026Mitchell Shawnte
Executive
SellCommon Stock$345.1K-15K
-100.00%
0
0.00% of shares
medium
Jan 14, 2026Myles David C.
Executive
SellCommon Stock$428.9K-15K
-2.53%
577,764
0.66% of shares
medium
Mar 4, 2026Mitchell Shawnte
Executive
SellCommon Stock$600.6K-25K
-99.07%
233
<0.01% of shares
medium
Jan 14, 2026Myles David C.
Executive
SellCommon Stock$1.01M-35K
-6.06%
542,761
0.62% of shares
medium
Jan 13, 2026Myles David C.
Executive
SellCommon Stock$1.37M-50K
-8.40%
542,961
0.62% of shares
medium
Jan 15, 2026Kovacs Shane William Charles
Executive
SellCommon Stock$2.87M-100K
-41.71%
139,727
0.16% of shares
medium
Jun 18, 2026Clark Ian T
Director
GrantStock Option (right to buy)—+30K
29,500
0.03% of shares
low
Jun 18, 2026Butitta Cynthia M
Director
GrantStock Option (right to buy)—+30K
29,500
0.03% of shares
low
Jun 18, 2026Rappaport Andrew
Director
GrantStock Option (right to buy)—+30K
29,500
0.03% of shares
low
Jun 18, 2026Bvf Partners L P/IL
Director
GrantStock Option (Right to buy)—+30K
29,500
0.03% of shares
low
Feb 2, 2026Bohen Sean
CEO
GrantPerformance Stock Options (Right to Buy)—+275K
275,000
0.31% of shares
low
Feb 2, 2026Bohen Sean
CEO
GrantStock Option (Right to Buy)—+850K
850,000
0.97% of shares
low
Feb 2, 2026Myles David C.
Executive
GrantPerformance Stock Options (Right to Buy)—+106K
106,250
0.12% of shares
low
Feb 2, 2026Myles David C.
Executive
GrantStock Option (Right to Buy)—+250K
250,000
0.29% of shares
low
Jan 14, 2026Myles David C.
Executive
ExerciseStock Option (Right to Buy)—-50K
-50.00%
50,000
0.06% of shares
low
Jan 13, 2026Myles David C.
Executive
ExerciseStock Option (Right to Buy)—-50K
-33.33%
100,000
0.11% of shares
low
Mar 4, 2026Mitchell Shawnte
Executive
ExerciseStock Option (Right to Buy)—-25K
-5.75%
410,000
0.47% of shares
low
Mar 3, 2026Mitchell Shawnte
Executive
ExerciseStock Option (Right to Buy)—-15K
-3.33%
435,000
0.50% of shares
low
Feb 2, 2026Austin Sasha Lu
Executive
GrantStock Option (Right to Buy)—+29K
29,250
0.03% of shares
low
Feb 2, 2026Zojwalla Naseem
Executive
GrantPerformance Stock Options (Right to Buy)—+106K
106,250
0.12% of shares
low
Feb 2, 2026Zojwalla Naseem
Executive
GrantStock Option (Right to Buy)—+250K
250,000
0.29% of shares
low
Feb 2, 2026Mitchell Shawnte
Executive
GrantPerformance Stock Options (Right to Buy)—+56K
56,250
0.06% of shares
low
Feb 2, 2026Mitchell Shawnte
Executive
GrantStock Option (Right to Buy)—+220K
220,000
0.25% of shares
low
← PrevPage 1 of 1Next →